What's Making News

August 8, 2017 - 10:50am

DMRF Canada is pleased to offer a one-year clinical fellowship to support the training of exceptionally qualified physicians in preparation for their clinical career in movement disorders with a focus on dystonia and a special competence in use of botulinum toxins. In 2017, this program will support fellows through a grant from Allergan.

July 27, 2017 - 4:49pm

We are thrilled to announce we recently received the much-needed funding to launch a support program specifically for parents of children and teens who have dystonia, as well as the children and teens who are affected by the disorder.

There will be many projects rolled out as part of this initiative, including the development of a number of research guides, for parents of children with dystonia, as well as for teens. 

Get Support Online

July 11, 2017 - 9:59am

According to the research, the childhood-onset motor disorder DYT6 dystonia is caused by loss-of-function mutations in the transcription factor THAP1, but the neurodevelopmental processes in which THAP1 participates are unknown.

June 15, 2017 - 3:28pm

Researchers at the University of California San Diego have developed a model and hypothesis to explain the origins of blepharospasm, a focal dystonia of the eyelid and brow muscles that cause involuntary blinking and eye closure.